StockData
IMMUTEP Ltd logo

IMMUTEP Ltd (IMMP) shareholders

IMMPNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRRUF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Oct 23, 2026Score 8/30
$3.26−0.14 (-4.12%)

Close on Nov 17, 2026Market cap $24.02MP/E –Yield –

Ownership

Who owns Immutep's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Marc VoigtSee Remarks, Director85,700Apr 13, 2026
Deanne Diem MillerChief Operating Officer2,867,305Apr 13, 2026
Christian MuellerChief Development Officer3,774,048Apr 1, 2026
Stephan Karel Gerard WinckelsChief Medical Officer92,935Apr 1, 2026
Elisabeth Amanda BoyceDirector423,288Apr 16, 2026
Pete A. MeyersDirector4,052,173Apr 7, 2026
Frederic Joseph Daniel TriebelDirector170,610Apr 1, 2026
Russell J. HowardDirector1,717,977Apr 1, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
2.4
At 0M shares a day
Change since last report
-1.1%
From 0M shares
Short volume, 20 days
59.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Immutep's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,787 shares on Aug 28, 2026 over the last 90 days.

See a number that looks wrong?